NCT03895008RecruitingNot Applicable
Comparing the Stage-for-Stage Prognosis of Patients With Cardia and Non-cardia Gastric Cancer After Operation.
Affiliated Hospital of Qinghai University3 sites in 1 country1,000 target enrollmentStarted: July 8, 2019Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 1,000
- Locations
- 3
- Primary Endpoint
- Disease Free Survival（DFS）
Study Overview
Brief Summary
To comparing the stage-for-stage prognosis of patients with cardia and non-cardia gastric cancer after operation.
Detailed Description
The aim of this study is to compare the stage-for-stage prognosis of patients with cardia and non-cardia gastric cancer after operation.In this study, patients with cardiac and non-cardiac gastric cancer who undergo radical resection from January 2019 to December 2024 will be included. We will follow up the patient's progression, recurrence time and survival time.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to 80 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Histopathology or cytopathology proven cardia or non-cardia gastric cancer;
- •Operable gastric cancer patients: primary lesions can be completely excision, no distant metastasis;
- •Life expectancy of at least 6 months;
- •ECOG（Eastern Cooperative Oncology Group ） score 0-1;
- •Age: 18~80 years old;
- •Normal hemodynamic indices before the recruitment (including blood cell count and liver/kidney function).
- •For example: WBC（White blood cell count ）>4.0×109/L; NEU（Neutrophils）>1.5×109/L; PLT（Platelet）>100×109/L;
- •Roughly normal cardiopulmonary function: No coronary heart disease, myocardial infarction, pulmonary heart disease, refractory hypertension;
- •Not concomitant with other uncontrollable benign diseases before the recruitment;
- •Voluntarily signed the informed consent.
Exclusion Criteria
- •Advanced gastric cancer patients with distant metastasis and inoperable ;
- •Pregnant or lactating women;
- •Patients who have no desire to participate in the study.
Outcomes
Primary Outcomes
Disease Free Survival（DFS）
Time Frame: 5 years
The time from the primary operation to disease recurrence or death.
Secondary Outcomes
- Overall survival(OS)(5 years)
Investigators
Jiuda Zhao
Professor
Affiliated Hospital of Qinghai University
Study Sites (3)
Loading locations...
Similar Trials
Completed
Not Applicable
Comparison of Long-term Outcomes Between Upfront Surgery and Neoadjuvant Therapy Followed by Surgery in Patients with Node-Negative Gastric CancerLymph Node-negativeGastric CancerNCT06673472Chang-Ming Huang, Prof.1,081
Unknown
Not Applicable
Study of CT and MR in the Gastric CancerGastric Cancer StageCTMRINeoadjuvant TherapyNCT04028375Henan Cancer Hospital400
Completed
Not Applicable
Prognostic Performance of the Naples Prognostic ScoreNutritional and Metabolic DiseasesOncologic DisordersNCT03272646University of Campania "Luigi Vanvitelli"477
Unknown
Not Applicable
Predictive Biomarkers in Stage II/III Gastric Cancer for Adjuvant ChemotherapyGastric CancerNCT01905969Iwate Medical University500
Recruiting
Not Applicable
Effect of Different Treatments on the Prognosis of Early Cervical Cancer: A Multicenter, Prospective, Real-world StudyCervical CancerNCT04272190Southern Medical University, China20,000